Tag: AstraZeneca

  • Comparison of Global Growth Stocks – 2. AZN

    Comparison of Global Growth Stocks – 2. AZN

    Summary: A comprehensive QC assessment of top growth stocks in Q1’23 was conducted, focusing on A-rated AstraZeneca PLC (AZN) in the biopharmaceutical industry. The company’s financial indicators, technical analysis, and algorithmic trading signals were analyzed. Backtesting showed a 34% profit from investing in AZN, outperforming the benchmark by 50%.